Mr. Speaker, I do not necessarily disagree or agree with that statement. If they are making it, that is fine. My basic assumption with free trade agreements is that we would probably increase the options available. If it takes longer to get the generic drug, that is probably the case. However, if we have an integration between the two areas of trade, Canada and the EU, we may increase the options for different kinds of drugs that are not necessarily available in Canada right now but may be available after the free trade agreement comes into force. We may not even have to use the particular drug that he was talking about before, as now we have a different one.
The other thing that comes into play, and I have mentioned this on and on, is the interplay between people, ideas, and things that would happen between our markets as we go to more and more free trade. We may actually find solutions to the problems that these drugs are trying to solve. We may make a particular drug obsolete and go on to a new one because of the interplay between the people, things, and ideas.